Biologic and Small Molecule Treatment for Seborrheic Dermatitis: An Evidence-Based Review

J Cutan Med Surg. 2024 Oct 13:12034754241290826. doi: 10.1177/12034754241290826. Online ahead of print.

Authors

Siddhartha Sood¹, Jonah Perlmutter¹, Khalad Maliyar², Abrahim Abduelmula², Asfandyar Mufti^{2

3}, Jensen Yeung^{2

3

4

5}

Affiliations

¹ Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
³ Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁴ Probity Medical Research, Waterloo, ON, Canada.
⁵ Department of Dermatology, Women's College Hospital, Toronto, ON, Canada.

PMID: 39397369
DOI: 10.1177/12034754241290826

No abstract available

Keywords: Janus kinase inhibitor; biologic; phosphodiesterase-4; seborrheic dermatitis; small molecule; systematic review.

Publication types

Letter